Suppr超能文献

肠造口瘘手术后的临床结局及复发预测因素

Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery.

作者信息

Lynch A Craig, Delaney Conor P, Senagore Anthony J, Connor Jason T, Remzi Feza H, Fazio Victor W

机构信息

Department of Colorectal Surgery, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

出版信息

Ann Surg. 2004 Nov;240(5):825-31. doi: 10.1097/01.sla.0000143895.17811.e3.

Abstract

OBJECTIVE

Recent experience with surgery for enterocutaneous fistulae (ECF) at a specialist colorectal unit is reviewed to define factors relating to a successful surgical outcome.

SUMMARY BACKGROUND DATA

ECF cause significant morbidity and mortality and need experienced surgical management. Previous publications have concentrated on mortality resulting from fistulae, while factors affecting recurrence have not previously been a focus of analysis.

METHODS

Records were reviewed of patients who had ECF surgery (1994-2001). Management strategy involved early drainage of sepsis and nutritional support prior to elective ECF repair, with selective defunctioning proximal stoma formation.

RESULTS

A total of 205 patients were available (89 males, 43%; median age, 51 years; range, 16-86) years). ECF were related to Crohn's disease in 95, ulcerative colitis in 18, diverticular disease in 17, carcinoma in 25 (16 after radiotherapy), mesh ventral hernia repair in 21, and other causes in 29. Forty-one (20%) had undergone attempted fistula repair at other institutions. Initial management included CT-guided drainage of an intra-abdominal abscess in 23 patients, and total parenteral nutrition in 74 (36%). A total of 203 patients had definitive ECF repair. Forty-four had oversewing or wedge resection of the fistula, and 159 had resection and reanastomosis of the involved small bowel segment or ileocolic anastomosis. Ninety-day operative mortality was 3.5%. A total of 42 (20.5%) patients developed ECF recurrence within 3 months. Multivariate analysis demonstrated that recurrence was more likely after oversewing (36%) than resection (16%, P = 0.006).

CONCLUSIONS

A strategy of drainage of acute sepsis, maintenance of nutritional support prior to surgery, and selective use of PS allows for primary closure in 80% of complicated ECF. Resection should be performed when feasible.

摘要

目的

回顾一家专业结直肠病治疗中心近期肠皮肤瘘(ECF)手术的经验,以确定与手术成功结果相关的因素。

总结背景资料

ECF会导致严重的发病率和死亡率,需要经验丰富的手术治疗。以往的出版物主要关注瘘导致的死亡率,而影响复发的因素此前并未成为分析的重点。

方法

回顾了接受ECF手术(1994 - 2001年)患者的记录。管理策略包括在择期ECF修复术前早期引流脓毒症和提供营养支持,并选择性地形成近端造口以解除肠道功能。

结果

共有205例患者(89例男性,占43%;中位年龄51岁;范围16 - 86岁)。95例ECF与克罗恩病有关,18例与溃疡性结肠炎有关,17例与憩室病有关,25例与癌症有关(16例为放疗后),21例与网状腹疝修补有关,29例由其他原因引起。41例(20%)曾在其他机构尝试过瘘修补术。初始治疗包括23例患者经CT引导下引流腹腔脓肿,74例(36%)患者接受全胃肠外营养。共有203例患者进行了确定性ECF修复。44例进行了瘘管缝合或楔形切除,159例进行了受累小肠段切除及吻合或回结肠吻合。90天手术死亡率为3.5%。共有42例(20.5%)患者在3个月内出现ECF复发。多因素分析表明,缝合术后复发的可能性(36%)高于切除术后(16%,P = 0.006)。

结论

急性脓毒症引流、术前维持营养支持以及选择性使用近端造口的策略可使80%的复杂性ECF实现一期闭合。可行时应进行切除。

相似文献

1
Clinical outcome and factors predictive of recurrence after enterocutaneous fistula surgery.
Ann Surg. 2004 Nov;240(5):825-31. doi: 10.1097/01.sla.0000143895.17811.e3.
4
Factors predictive of recurrence and mortality after surgical repair of enterocutaneous fistula.
J Gastrointest Surg. 2012 Jan;16(1):156-63; discussion 163-4. doi: 10.1007/s11605-011-1703-7. Epub 2011 Oct 15.
5
[Investigation of treatment and analysis of prognostic risk on enterocutaneous fistula in China: a multicenter prospective study].
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Nov 25;22(11):1041-1050. doi: 10.3760/cma.j.issn.1671-0274.2019.11.007.
6
Surgical management of entero and colocutaneous fistulae in Crohn's disease: 17 year's experience.
Int J Colorectal Dis. 2004 Sep;19(5):481-5; discussion 486. doi: 10.1007/s00384-004-0580-x. Epub 2004 May 26.
7
Predictive value of preoperative serum C-reactive protein for recurrence after definitive surgical repair of enterocutaneous fistula.
Am J Surg. 2017 Jan;213(1):105-111. doi: 10.1016/j.amjsurg.2016.05.008. Epub 2016 Jun 16.
8
Enterocutaneous fistula: a single-centre experience.
ANZ J Surg. 2010 Mar;80(3):178-81. doi: 10.1111/j.1445-2197.2009.05086.x.
9
Risk factors for recurrence after repair of enterocutaneous fistula.
Arch Surg. 2009 Jun;144(6):500-5. doi: 10.1001/archsurg.2009.66.

引用本文的文献

1
Gastrointestinal Fistulas-What Gastroenterologists Need to Know in 2025.
Can J Gastroenterol Hepatol. 2025 Aug 13;2025:6210421. doi: 10.1155/cjgh/6210421. eCollection 2025.
2
Catheter Injectable Multifunctional Biomaterial for the Treatment of Infected Enterocutaneous Fistulas.
Adv Sci (Weinh). 2025 May;12(20):e2414642. doi: 10.1002/advs.202414642. Epub 2025 Feb 14.
4
Injectable Nanoengineered Adhesive Hydrogel for Treating Enterocutaneous Fistulas.
Acta Biomater. 2024 Jan;173:231-246. doi: 10.1016/j.actbio.2023.10.026. Epub 2023 Oct 28.
5
A review of platelet-rich plasma for enteric fistula management.
Front Bioeng Biotechnol. 2023 Nov 15;11:1287890. doi: 10.3389/fbioe.2023.1287890. eCollection 2023.
6
Adipose tissue-derived stem cells as a therapeutic strategy for enterocutaneous fistula: an experimental model study.
Acta Cir Bras. 2023 Oct 13;38:e384523. doi: 10.1590/acb384523. eCollection 2023.
7
Superior Mesenteric Artery (SMA) Syndrome With Enterocutaneous Fistula in a Young Woman: A Rare Association.
Cureus. 2023 May 30;15(5):e39696. doi: 10.7759/cureus.39696. eCollection 2023 May.
8
Cecocutaneous fistula diagnosed by computed tomography fistulography: A case report.
World J Gastrointest Surg. 2022 Oct 27;14(10):1161-1168. doi: 10.4240/wjgs.v14.i10.1161.
9
Treatment of enterocutaneous fistula: a systematic review and meta-analysis.
Tech Coloproctol. 2022 Nov;26(11):863-874. doi: 10.1007/s10151-022-02656-3. Epub 2022 Aug 1.

本文引用的文献

1
Vacuum assisted closure system in the management of enterocutaneous fistulae.
Postgrad Med J. 2002 Jun;78(920):364-5. doi: 10.1136/pmj.78.920.364.
2
Nutrition and enterocutaneous fistulas.
J Clin Gastroenterol. 2000 Oct;31(3):195-204. doi: 10.1097/00004836-200010000-00003.
5
Management of intra-abdominal abscesses in Crohn's disease.
Ann R Coll Surg Engl. 1996 Jan;78(1):5-10.
6
Randomized trial of fibrin tissue glue for low output enterocutaneous fistula.
Br J Surg. 1996 Jan;83(1):112. doi: 10.1002/bjs.1800830135.
7
Small-bowel fistulas complicating midline surgical wounds.
J Wound Ostomy Continence Nurs. 1994 Jul;21(4):161-5. doi: 10.1097/00152192-199407000-00011.
9
Factors influencing the outcome of treatment of small bowel cutaneous fistula.
World J Surg. 1983 Jul;7(4):481-8. doi: 10.1007/BF01655937.
10
A technique for the operative closure of persistent external small-bowel fistulas.
Aust N Z J Surg. 1981 Oct;51(5):477-85. doi: 10.1111/j.1445-2197.1981.tb05990.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验